News & Events :: Can-Fite BioPharma Ltd. (CANF)

Recent News View All News

Jun 16, 2025 9:00am EDT

Can-Fite to Present Phase IIa Pancreatic Cancer Study Progress During Partnering Meetings at the 2025 BIO International Convention in Boston

May 5, 2025 8:00am EDT

Can-Fite Has Raised $175 Million in Total to Date for the Development of Namodenoson and Piclidenoson, Advancing into Pivotal Phase 3 Trials in Liver Cancer and Psoriasis

Recent Events View IR Calendar

Jun 30, 2025 3:00 pm IDT

2025 Annual General Meeting of Shareholders

Jun 16 – Jun 19, 2025

2025 BIO International Convention

View IR Calendar

Email Alerts

Sign up for email alerts for Press Releases & SEC Filings